Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03123055
Title A Study of B-701 in Combination With Atezolizumab in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma (U22)
Acronym FIERCE-22
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors BioClin Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | TUR | SWE | POL | NLD | ITA | HUN | FRA | ESP | DNK | DEU | BEL


No variant requirements are available.